An annual one-hour Abnormal Involuntary Movement Score (AIMS) training session improves documentation to recognize and treat tardive dyskinesia in the psychiatry outpatient clinic, according to a ...

For schizophrenia patients with tardive dyskinesia (TD), there may be sex differences in cognitive impairment, with a protective effect suggested by female gender, according to a study published in ...

At each clinical visit, patients on antipsychotics should be assessed for tardive dyskinesia (TD) and abnormal involuntary movements, according to American Psychiatric Association (APA) guidelines.

The findings of this study align with prior research that suggests lower effective doses of clozapine are required for patients of Indian descent compared to Western populations. Switching patients of ...

The gold standard is the Abnormal Involuntary Movement Scale, or the AIMS, although generally we kind of want to avoid premature TD labels, and we want to ensure that there's a causal link, in this ...

Tardive Dyskinesia TD as a neurological disorder resulting in involuntary repetitive movement disorder as a disease of brain Neurology due to dopamine problems. What have studies said the role vitamin ...

You may be able to reduce tardive dyskinesia with treatment. Some lifestyle behaviors, like getting enough sleep and exercise, can help. Tardive dyskinesia is a side effect of neuroleptic or ...

Please provide your email address to receive an email when new articles are posted on . Patients took 40 mg or 80 mg of daily valbenazine for 48 weeks. The Abnormal Involuntary Movement Scale was used ...

Tardive dyskinesia is a hyperkinetic movement disorder that causes faces to move involuntarily and abnormally. It is considered to be a drug-induced movement disorder. Movements often occur in the ...

This week, valbenazine became the first-ever drug approved by the Food and Drug Administration (FDA) for the treatment of tardive dyskinesia. Today, Psych Unseen answers some questions about the ...